526 related articles for article (PubMed ID: 9933348)
1. Evaluation of l-3-[123I]iodo-alpha-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy.
Bader JB; Samnick S; Moringlane JR; Feiden W; Schaefer A; Kremp S; Kirsch CM
Eur J Nucl Med; 1999 Feb; 26(2):144-51. PubMed ID: 9933348
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive grading of primary brain tumours: results of a comparative study between SPET with 123I-alpha-methyl tyrosine and PET with 18F-deoxyglucose.
Woesler B; Kuwert T; Morgenroth C; Matheja P; Palkovic S; Schäfers M; Vollet B; Schäfers K; Lerch H; Brandau W; Samnick S; Wassmann H; Schober O
Eur J Nucl Med; 1997 Apr; 24(4):428-34. PubMed ID: 9096095
[TBL] [Abstract][Full Text] [Related]
3. 3-[123I]Iodo-alpha-methyl-L-tyrosine uptake in cerebral gliomas: relationship to histological grading and prognosis.
Schmidt D; Gottwald U; Langen KJ; Weber F; Hertel A; Floeth F; Felsberg J; Reifenberger G; Coenen HH; Müller-Gärtner HW
Eur J Nucl Med; 2001 Jul; 28(7):855-61. PubMed ID: 11504082
[TBL] [Abstract][Full Text] [Related]
4. Differentiation between recurrent brain tumour and post-radiation necrosis: the value of 201Tl SPET versus 18F-FDG PET using a dual-headed coincidence camera--a pilot study.
Stokkel M; Stevens H; Taphoorn M; Van Rijk P
Nucl Med Commun; 1999 May; 20(5):411-7. PubMed ID: 10404525
[TBL] [Abstract][Full Text] [Related]
5. Detection of tumour progression in the follow-up of irradiated low-grade astrocytomas: comparison of 3-[123I]iodo-alpha-methyl- L-tyrosine and 99mTc-MIBI SPET.
Henze M; Mohammed A; Schlemmer H; Herfarth KK; Mier W; Eisenhut M; Debus J; Haberkorn U
Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1455-61. PubMed ID: 12397464
[TBL] [Abstract][Full Text] [Related]
6. Clinical value of iodine-123-alpha-methyl-L-tyrosine single-photon emission tomography in the differential diagnosis of recurrent brain tumor in patients pretreated for glioma at follow-up.
Samnick S; Bader JB; Hellwig D; Moringlane JR; Alexander C; Romeike BF; Feiden W; Kirsch CM
J Clin Oncol; 2002 Jan; 20(2):396-404. PubMed ID: 11786566
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours.
Sasaki M; Kuwabara Y; Yoshida T; Nakagawa M; Fukumura T; Mihara F; Morioka T; Fukui M; Masuda K
Eur J Nucl Med; 1998 Sep; 25(9):1261-9. PubMed ID: 9724375
[TBL] [Abstract][Full Text] [Related]
8. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors.
Weber W; Bartenstein P; Gross MW; Kinzel D; Daschner H; Feldmann HJ; Reidel G; Ziegler SI; Lumenta C; Molls M; Schwaiger M
J Nucl Med; 1997 May; 38(5):802-8. PubMed ID: 9170450
[TBL] [Abstract][Full Text] [Related]
9. [Metabolic imaging to follow stereotactic radiation of gliomas -- the role of 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT].
Lichy MP; Henze M; Plathow C; Bachert P; Kauczor HU; Schlemmer HP
Rofo; 2004 Aug; 176(8):1114-21. PubMed ID: 15346287
[TBL] [Abstract][Full Text] [Related]
10. Sequential scintigraphic strategy for the differentiation of brain tumours.
Matheja P; Rickert C; Weckesser M; Palkovic S; Löttgen J; Riemann B; Kopka K; Kuwert T; Wassmann H; Paulus W; Schober O
Eur J Nucl Med; 2000 May; 27(5):550-8. PubMed ID: 10853811
[TBL] [Abstract][Full Text] [Related]
11. High uptake of L-3-[123I]iodo-alpha-methyl tyrosine in pilocytic astrocytomas.
Weckesser M; Matheja P; Rickert CH; Sträter R; Palkovic S; Löttgen J; Kurlemann G; Paulus W; Wassmann H; Schober O
Eur J Nucl Med; 2001 Mar; 28(3):273-81. PubMed ID: 11315593
[TBL] [Abstract][Full Text] [Related]
12. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.
Kaschten B; Stevenaert A; Sadzot B; Deprez M; Degueldre C; Del Fiore G; Luxen A; Reznik M
J Nucl Med; 1998 May; 39(5):778-85. PubMed ID: 9591574
[TBL] [Abstract][Full Text] [Related]
13. Uptake of iodine-123-alpha-methyl tyrosine by gliomas and non-neoplastic brain lesions.
Kuwert T; Morgenroth C; Woesler B; Matheja P; Palkovic S; Vollet B; Samnick S; Maasjosthusmann U; Lerch H; Gildehaus FJ; Wassmann H; Schober O
Eur J Nucl Med; 1996 Oct; 23(10):1345-53. PubMed ID: 8781139
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of recurrent head and neck squamous cell carcinoma with 3-[123I]iodo-L-alpha-methyltyrosine SPET.
Dierickx LO; Lahoutte T; Deron P; Caveliers V; Vanhove C; Everaert H; Bossuyt A
Eur J Nucl Med; 2001 Mar; 28(3):282-7. PubMed ID: 11315594
[TBL] [Abstract][Full Text] [Related]
15. Use of positron emission tomography (PET) in stereotactic conditions for brain biopsy.
Pirotte B; Goldman S; Bidaut LM; Luxen A; Stanus E; Brucher JM; Balériaux D; Brotchi J; Levivier M
Acta Neurochir (Wien); 1995; 134(1-2):79-82. PubMed ID: 7668134
[TBL] [Abstract][Full Text] [Related]
16. Initial evaluation of the feasibility of single photon emission tomography with p-[123 I]iodo-L-phenylalanine for routine brain tumour imaging.
Samnick S; Hellwig D; Bader JB; Romeike BF; Moringlane JR; Feiden W; Kirsch CM
Nucl Med Commun; 2002 Feb; 23(2):121-30. PubMed ID: 11891465
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment evaluation of carcinomas of the hypopharynx and larynx with 18F-fluorodeoxyglucose, 123I-alpha-methyl-L-tyrosine and 99mTc-hexakis-2-methoxyisobutylisonitrile.
Henze M; Mohammed A; Mier W; Rudat V; Dietz A; Nollert J; Eisenhut M; Haberkorn U
Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):324-30. PubMed ID: 12002706
[TBL] [Abstract][Full Text] [Related]
18. Intra-individual comparison of p-[123I]-iodo-L-phenylalanine and L-3-[123I]-iodo-alpha-methyl-tyrosine for SPECT imaging of gliomas.
Hellwig D; Romeike BF; Ketter R; Moringlane JR; Kirsch CM; Samnick S
Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):24-31. PubMed ID: 17846769
[TBL] [Abstract][Full Text] [Related]
19. Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value.
Van Laere K; Ceyssens S; Van Calenbergh F; de Groot T; Menten J; Flamen P; Bormans G; Mortelmans L
Eur J Nucl Med Mol Imaging; 2005 Jan; 32(1):39-51. PubMed ID: 15309329
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of diagnostic accuracy of (18)F-FDG PET, (123)I-IMT- and (99m)Tc-MIBI SPECT: evaluation of tumour progression in irradiated low grade astrocytomas].
Henze M; Ozdemir-Sahin N; Hipp P; Mier W; Eisenhut M; Debus J; Haberkorn U
Nuklearmedizin; 2006; 45(1):49-56. PubMed ID: 16493514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
